Healthcare > Medical Devices & Equipment
•1105 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1105)
| Company | Market Cap | Price |
|---|---|---|
|
STE
STERIS plc
STERIS provides medical device consumables (sterility products, detergents, and related supplies) integral to sterilization workflows.
|
$24.80B |
$254.58
+1.11%
|
|
VLTO
Veralto Corporation
Veralto may offer laboratory testing and advisory services around water quality testing and compliance.
|
$24.50B |
$99.93
+1.24%
|
|
WAT
Waters Corporation
Waters supplies diagnostic instruments used in laboratories for analytical testing and qualification workflows.
|
$22.94B |
$384.11
-0.32%
|
|
UTHR
United Therapeutics Corporation
Tyvaso DPI and Remunity Pump are medical devices for drug delivery, reflecting UTHR's device-based delivery platforms.
|
$22.34B |
$497.83
+0.78%
|
|
LH
Labcorp Holdings Inc.
Labcorp offers liquid biopsy tests (e.g., MRD portfolios) as part of its oncology testing portfolio.
|
$21.95B |
$262.34
-0.70%
|
|
PODD
Insulet Corporation
Insulet's core business is medical devices and equipment, anchored by the Omnipod insulin pump platform.
|
$20.82B |
$293.04
-0.90%
|
|
CHD
Church & Dwight Co., Inc.
Waterpik dental water flossers and related oral-care devices are dental equipment products.
|
$20.61B |
$85.00
+0.46%
|
|
DGX
Quest Diagnostics Incorporated
Quest provides laboratory testing services and advisory/regulatory support for microbiology and analytical workflows.
|
$20.41B |
$183.96
+0.76%
|
|
WST
West Pharmaceutical Services, Inc.
West designs and manufactures medical devices and delivery systems (e.g., autoinjectors, prefilled syringes).
|
$19.24B |
$271.90
+1.62%
|
|
EXAS
Exact Sciences Corporation
Exact Sciences’ pipeline includes blood-based cancer diagnostics (liquid biopsy) such as Oncodetect MRD and blood-based CRC test programs, making Liquid Biopsy a core product category.
|
$19.22B |
$101.56
+0.06%
|
|
SNA
Snap-on Incorporated
RS&I segment includes diagnostic equipment and repair information software platforms.
|
$18.30B |
$352.37
+0.44%
|
|
ZBH
Zimmer Biomet Holdings, Inc.
Zimmer Biomet's core orthopedic devices business centers on joint implants (hips and knees) and related prosthetics.
|
$18.14B |
$92.46
+0.95%
|
|
THC
Tenet Healthcare Corporation
Tenet operates hospitals and hospital-based care delivering inpatient and outpatient services.
|
$17.62B |
$197.76
-0.82%
|
|
HOLX
Hologic, Inc.
Panther Panther Fusion molecular diagnostics platform and Aptima/BV/CV/TV assays are diagnostic equipment sold by Hologic.
|
$16.68B |
$75.14
+0.19%
|
|
COO
The Cooper Companies, Inc.
CooperVision and CooperSurgical primarily manufacture ophthalmology devices and related vision-care products, fitting Ophthalmology Devices.
|
$16.32B |
$81.04
-1.27%
|
|
MEDP
Medpace Holdings, Inc.
Provides Laboratory Testing & Advisory Services including bio-analytical labs and regulatory support as a CRO service.
|
$15.67B |
$559.87
+0.35%
|
|
ULS
UL Solutions Inc.
UL Solutions offers Laboratory Testing & Advisory Services, including regulatory advisory and compliance support.
|
$15.64B |
$77.20
-0.87%
|
|
ROIV
Roivant Sciences Ltd.
Auto-injector devices enabling at-home administration for IMVT-1402, fitting Auto-Injector Devices.
|
$15.09B |
$21.73
-1.70%
|
|
SOLV
Solventum Corporation
V.A.C. Peel and Place dressing is a wound care device, a core MedSurg product.
|
$14.39B |
$81.69
-1.55%
|
|
UHS
Universal Health Services, Inc.
UHS directly provides hospital inpatient and related acute care services.
|
$14.17B |
$224.11
+0.68%
|
|
FMS
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care manufactures and provides Blood Purification Devices used in dialysis, including the 5008X CAREsystem.
|
$13.85B |
$23.64
+0.17%
|
|
NDSN
Nordson Corporation
Atrion's medical components and medical device technologies place Nordson in the medical devices & biometrics space.
|
$13.31B |
$237.29
+0.78%
|
|
GH
Guardant Health, Inc.
Core product category: Guardant Health's liquid biopsy tests (Guardant360 Liquid/Tissue) are the primary offerings.
|
$12.73B |
$102.97
+0.88%
|
|
TEM
Tempus AI, Inc.
Laboratory Testing & Advisory Services – Tempus provides outsourced laboratory testing and regulatory/advisory support.
|
$12.27B |
$69.36
-1.77%
|
|
PEN
Penumbra, Inc.
Penumbra's core offerings include vascular intervention devices used for thrombectomy and catheter-based clot removal.
|
$12.17B |
$310.48
-0.50%
|
|
ALGN
Align Technology, Inc.
Align's Invisalign system, iTero scanners, and direct 3D-printed dental devices are core dental equipment products.
|
$11.99B |
$163.87
-0.95%
|
|
GMED
Globus Medical, Inc.
Orthopedic devices and implants (spinal, ALIF spacers, knee systems) sold for reconstruction.
|
$11.71B |
$86.81
+0.13%
|
|
RVTY
Revvity, Inc.
Revvity's Diagnostics segment includes diagnostic equipment and instruments.
|
$11.66B |
$98.67
-1.81%
|
|
EHC
Encompass Health Corporation
Encompass Health operates inpatient rehabilitation hospital services, aligning with the Hospital Services investable theme.
|
$10.78B |
$107.47
+0.44%
|
|
QGEN
Qiagen N.V.
QIAGEN directly manufactures diagnostic instruments (e.g., QIAstat-Dx, QIAcuity, QIAsymphony Connect) and automated platforms.
|
$10.12B |
$45.22
-0.01%
|
|
BAX
Baxter International Inc.
Novum IQ infusion platform is a medical device platform core to Baxter's Medical Devices & Equipment offerings.
|
$9.84B |
$19.80
+3.37%
|
|
CRL
Charles River Laboratories International, Inc.
CRL offers outsourced laboratory testing and advisory/regulatory support services in non-clinical research and safety testing.
|
$9.50B |
$197.90
+2.52%
|
|
HSIC
Henry Schein, Inc.
Henry Schein directly distributes dental equipment to dental practices, aligning with its core product offerings.
|
$9.28B |
$77.44
+1.16%
|
|
TECH
Bio-Techne Corporation
Medical device consumables are used with Bio-Techne's instruments and reagents, contributing recurring revenue.
|
$9.10B |
$58.34
-0.28%
|
|
DVA
DaVita Inc.
DaVita provides outpatient dialysis clinics and related kidney care services, aligning with hospital/healthcare services in a medical facility setting.
|
$8.68B |
$120.92
-0.35%
|
|
HIMS
Hims & Hers Health, Inc.
Laboratory testing & advisory services core to in-house lab capabilities.
|
$8.41B |
$36.42
-2.12%
|
|
BIO
Bio-Rad Laboratories, Inc.
Bio-Rad directly manufactures and sells diagnostic instruments and related equipment used in clinical laboratories.
|
$8.34B |
$306.75
-0.45%
|
|
ATR
AptarGroup, Inc.
Aptar supplies medical devices/equipment relevant to pharma and healthcare, including device components and sterilization tech.
|
$8.00B |
$121.83
+0.30%
|
|
AVTR
Avantor, Inc.
Avantor provides Laboratory Testing & Advisory Services, aligning with outsourced testing and regulatory support offerings.
|
$7.62B |
$11.13
-0.31%
|
|
MASI
Masimo Corporation
Primary revenue comes from patient monitoring devices and systems sold to healthcare providers.
|
$7.52B |
$137.04
-0.94%
|
|
HALO
Halozyme Therapeutics, Inc.
Halozyme is expanding its portfolio of auto-injector devices to enable at-home/self-administration of therapies.
|
$7.28B |
$62.71
+0.80%
|
Showing page 2 of 12 (1105 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...